发明名称 |
Methods of treating amyotrophic lateral sclerosis |
摘要 |
The present invention relates to use of DHA analogs and their pharmaceutical compositions for treating ALS, by administering these compounds or pharmaceutical compositions to subjects in need thereof. |
申请公布号 |
US9340483(B2) |
申请公布日期 |
2016.05.17 |
申请号 |
US201314379177 |
申请日期 |
2013.02.15 |
申请人 |
ANIDA PHARMA INC. |
发明人 |
Gjorstrup Per |
分类号 |
A61K31/202;C07C59/42;A61K45/06 |
主分类号 |
A61K31/202 |
代理机构 |
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. |
代理人 |
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. |
主权项 |
1. A method for reducing oxidative stress associated with amyotrophic lateral sclerosis (ALS) comprising administering to a subject in need thereof a therapeutically effective amount of a compound of Formula I: or a pharmaceutically acceptable salt, ester, solvate, hydrate or prodrug thereof, wherein reducing oxidative stress associated with ALS comprises one or more of (a) reducing cell death; (b) reducing neurodegeneration; or (c) increasing cell survival of a cell from the subject suffering from ALS, wherein said cell is a motor neuron and said method increases motor neuron survival by at least 39%. |
地址 |
Cambridge MA US |